Emerging Protein Bio Therapeutics

Therapeutic proteins and monoclonal antibodies (MAb) have transformed biotechnology and the pharmaceutical industry. Together they form the largest part of the rapidly growing biologics drug market. Protein-based drugs include blood factors, thrombolytic agents, hormones, hematopoietic growth factors, interferons, interleukins, tumor necrosis factor, and therapeutic enzymes. 

  • Protein Particulate Detection Issues in Biotherapeutics Development
  • Analytical Development For Emerging Biotherapeutics
  • Automation And Emerging Analytical Methods
  • Bioanalytical Considerations Of Multi-Domain Biotherapeutics: Preclinical And Clinical Development

Emerging Protein Bio Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in